Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia
Hardikkumar Jetani, Almudena Navarro‐Bailón, Marius Maucher, et al.
Blood (2021) Vol. 138, Iss. 19, pp. 1830-1842
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
Xiaomin Zhang, Lingling Zhu, Hui Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 209
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia
Adrian Gottschlich, Moritz Thomas, Ruth Grünmeier, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 11, pp. 1618-1632
Open Access | Times Cited: 60
Metabolic challenges and interventions in CAR T cell therapy
Jhan-Jie Peng, Limei Wang, Zhiyu Li, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Closed Access | Times Cited: 59
Cooperative CAR targeting to selectively eliminate AML and minimize escape
Sascha Haubner, Jorge Mansilla‐Soto, Sarah Nataraj, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1871-1891.e6
Open Access | Times Cited: 43
Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing
Jacob Appelbaum, April E. Price, Kaori Oda, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 9
Open Access | Times Cited: 17
Siglec Signaling in the Tumor Microenvironment
Eline J.H. van Houtum, Christian Büll, Lenneke A. M. Cornelissen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 66
Targeting the Siglec–Sialic Acid Immune Axis in Cancer: Current and Future Approaches
Heinz Laübli, Sam C. Nalle, Daniel Maslyar
Cancer Immunology Research (2022) Vol. 10, Iss. 12, pp. 1423-1432
Open Access | Times Cited: 53
Intraparticle Double‐Scattering‐Decoded Sonogenetics for Augmenting Immune Checkpoint Blockade and CAR‐T Therapy
Duo Wang, Mengqi Zhang, Yan Zhang, et al.
Advanced Science (2022) Vol. 9, Iss. 32
Open Access | Times Cited: 51
Tumor buster - where will the CAR-T cell therapy ‘missile’ go?
Chunrun Qu, Hao Zhang, Hui Cao, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 45
The Black Hole: CAR T Cell Therapy in AML
Erden Atilla, Karim Benabdellah
Cancers (2023) Vol. 15, Iss. 10, pp. 2713-2713
Open Access | Times Cited: 36
CAR-T cell therapy: Where are we now, and where are we heading?
Jiayi Wang, Liang Wang
Blood Science (2023) Vol. 5, Iss. 4, pp. 237-248
Open Access | Times Cited: 25
Challenges and strategies associated with CAR-T cell therapy in blood malignancies
Zhaoyun Liu, Wenhui Lei, Hao Wang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Hotspots evolution and frontiers of immunotherapy for the treatment of acute myeloid leukemia: A bibliometric analysis
Nana Zhe, Qiang Li, Nanqu Huang, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 1
CAR T or NK cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant
Shunya Ikeda, Kana Hasegawa, Yosuke Kogue, et al.
Nature Cancer (2025)
Closed Access | Times Cited: 1
Recent advances of CAR-T cells in acute myeloid leukemia
Huan Deng, Qi Wang, Xiaodong Tong, et al.
Therapeutic Advances in Hematology (2025) Vol. 16
Open Access | Times Cited: 1
Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia
Jennifer Marvin‐Peek, Bipin N. Savani, Olalekan O. Oluwole, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 497-497
Open Access | Times Cited: 30
Biomarkers as targets for CAR-T/NK cell therapy in AML
Ruonan Shao, Zijian Li, Hong-Lei Xin, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Siglec-6 mediates the uptake of extracellular vesicles through a noncanonical glycolipid binding pocket
Edward N. Schmidt, Dimitra Lamprinaki, Kelli A. McCord, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
CAR-T-Cell-Based Cancer Immunotherapies: Potentials, Limitations, and Future Prospects
Mahmood S. Choudhery, Taqdees Arif, Ruhma Mahmood, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3202-3202
Open Access | Times Cited: 7
A bibliometric and knowledge-map study on the treatment of hematological malignancies with CAR-T cells from 2012 to 2023
Qing Huang, Huimin Li, Yuan Zhang
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 7
The Potential of Siglecs and Sialic Acids as Biomarkers and Therapeutic Targets in Tumor Immunotherapy
Haokang Feng, Jiale Feng, Xu Han, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 289-289
Open Access | Times Cited: 6
Glycosylation Targeting: A Paradigm Shift in Cancer Immunotherapy
Xueting Ren, Shuai Lin, Feng Guan, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 7, pp. 2607-2621
Open Access | Times Cited: 6
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia
Benjamin Caulier, Sandy Joaquina, Pascal Gélébart, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101572-101572
Open Access | Times Cited: 6
A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges
Ying Chen, Jishi Wang, Fengqi Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells
Piper A. Robida, Clayton H. Rische, Netali Ben-Baruch Morgenstern, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1138-1138
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top